The medical-surgical segment of the healthcare market grew 6.3 percent in the second quarter to $9.1bn in volume and 2.3 percent growth compared to second quarter 2015 ($8.6bn), and the clinical laboratory product segment decreased 5.1 percent to $1.9bn in the second quarter compared to results in second quarter 2015 ($1.8bn).
The modern, technology-based supply chain has evolved from a back-end, transactional function to a means to not only strip waste and costs out of healthcare, but increasingly to help create better clinical outcomes. GHX, an electronic healthcare industry trading exchange, has identified five ways in which its customers are leveraging their supply chains to markedly improve patient care.